🛡️ Public data only — no PHI permitted on this instance.
SC
SeekingChartis
Investment Committee Memorandum | FL | 167 beds | Grade B | EBITDA uplift $24.4M
Investment Committee Memorandum

ORLANDO HEALTH SOUTH LAKE HOSPITAL

CCN 100051 | LAKE, FL | 167 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

ORLANDO HEALTH SOUTH LAKE HOSPITAL is a 167-bed suburban community hospital in LAKE, FL with $331.8M in net patient revenue and a 7.2% operating margin. The hospital serves a payer mix of 28.9% Medicare, 2.3% Medicaid, and 68.8% commercial.

Thesis: Turnaround. Our ML models identify $24.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.2% to 14.5% (+736bps).

Net Revenue HCRIS$331.8M
Current EBITDA COMPUTED$23.8M
Operating Margin COMPUTED7.2%
Occupancy HCRIS89.3%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS14.0%
Distress Probability ML36.3%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
123
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 7.2% places it above the state median. Among 123 size-comparable peers (84-334 beds), the median margin is 2.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (84-334), prioritizing same-state peers. 123 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ORLANDO HEALTH SOUTH LAKE HOSP (Target)FL167$331.8M7.2%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
JOHNS HOPKINS ALL CHILDRENS HOFL259$584.5M-10.3%
HOLY CROSS HOSPITALFL286$566.3M-0.7%
ADVENTHEALTH DAYTONA BEACHFL330$532.7M-1.9%
CCF HOSPITAL - WESTONFL258$465.4M-3.8%
DELRAY MEDICAL CENTERFL324$453.3M12.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $24.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.0M+210bp18mo
Cost to Collect4.5%2.5%$6.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.0M+122bp9mo
Clean Claim Rate88.0%96.0%$212K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.0M
Cost to Collect
$6.6M
Denial Rate Reduction
$6.6M
A/R Days Reduction
$4.0M
Clean Claim Rate
$212K
Total EBITDA Uplift$24.4M
Current EBITDA$23.8M
+ RCM Uplift+$24.4M
Pro Forma EBITDA$48.2M
Current Margin7.2%
Pro Forma Margin14.5%
WC Released (1x)$12.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$36.6M$401.1M10.96x61.4%
Base (11x exit)10.0x11.0x$36.6M$453.0M12.38x65.4%
Bull Case9.0x11.0x$32.9M$545.5M16.57x75.3%
Bull (12x exit)9.0x12.0x$32.9M$604.8M18.37x79.0%
Bear Case11.0x10.0x$40.2M$267.1M6.64x46.0%
Bear (11x exit)11.0x11.0x$40.2M$306.8M7.63x50.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 123 hospitals with 84-334 beds
  • Same-state prioritization (n=124)
  • Comp margins: P25=-5.7% / P50=2.8% / P75=16.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.

Full EBITDA BridgeML AnalysisHospital ProfileStatistical ProfileDeal Screener